e-learning
resources
London 2016
Sunday, 04.09.2016
Possible phenotypes of bronchiectasis and exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
James D. Chalmers (Perth, United Kingdom), Anthony De Soyza, Melissa J. McDonnell, John Davidson, Pieter C. Goeminne, Adam T. Hill, Eva Polverino, Stefano Aliberti, James D. Chalmers, On Behalf of EMBARC
Source:
International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Session:
Possible phenotypes of bronchiectasis and exacerbations
Session type:
Poster Discussion
Number:
1541
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
James D. Chalmers (Perth, United Kingdom), Anthony De Soyza, Melissa J. McDonnell, John Davidson, Pieter C. Goeminne, Adam T. Hill, Eva Polverino, Stefano Aliberti, James D. Chalmers, On Behalf of EMBARC. Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry. Eur Respir J 2016; 48: Suppl. 60, 1541
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Exacerbations of bronchiectasis: Etiology and outcome
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
The relationship between COPD and periodontitis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Bronchiectasis is common in severe asthma
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Characterization of asthma exacerbations in outpatients – National survey
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept